Company: PTPI
Filing Date: 2025-05-02
Form Type: 8-K
Source: 0001104659-25-044240
Chunk: 0

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-05-02
Form: 8-K
Item: Item 3.03
Chunk 0
---
Item 3.03. Material Modification to Rights
of Security Holders.

To the extent required by Item 3.03 of Form 8-K,
the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference.

Item 5.03. Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year.

On April 29, 2025, the Company filed a Certificate
of Amendment (the “ Certificate of Amendment”) of Amended and Restated Certificate of Incorporation (the “ Certificate
of Incorporation”) with the Secretary of State of Delaware to effect a 1-for-25 reverse stock split of the shares of the
Company’s Common Stock either issued and outstanding or held by the Company as treasury stock, effective as of 4:05 p. m. (New York
time) on April 30, 2025 (the “ Reverse Stock Split”). As previously disclosed, the Company held its 2024 annual
meeting of stockholders (the “ Annual Meeting”) on November 20, 2024, at which meeting the Company’s stockholders
approved the amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Common Stock at a ratio
in the range of 1-for-2 to 1-for-25, with such ratio to be determined by the Company’s Board of Directors (the “ Board”)
and included in a public announcement. Following the Annual Meeting, the Board determined to effect the Reverse Stock Split at a ratio
of 1-for-25 and approved the corresponding final form of the Certificate of Amendment.

As a result of the Reverse Stock Split, every
25 shares of issued and outstanding Common Stock was automatically combined into one issued and outstanding share of Common Stock without
any change in the par value per share. No fractional shares were issued as a result of the Reverse Stock Split. Any fractional shares
that would otherwise have resulted from the Reverse Stock Split were rounded up to the next whole number. The number of authorized shares
of Common Stock under the Certificate of Incorporation remains unchanged at 7,000,000,000 shares.

Proportionate adjustments were made to the per
share exercise price and the number of shares of Common Stock that may be purchased upon exercise of outstanding stock options granted
by the Company. The number of shares reserved for issuance under the Company’s 2020 Omnibus Incentive Compensation Plan (the “2020
Plan”) was